Jeito Capital announces the acquisition by Merck & Co (NYSE: MRK) of its portfolio company EyeBio for a potential value of $3 billion
GlobeNewswire
*Jeito Capital announces the acquisition by Merck & Co (NYSE: MRK)*
*of its portfolio company* *EyeBio for a potential..